# CeGaT

Source: https://onco.cc/companies/cegat/  
OnCo record `cegat` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

CeGaT, a Tübingen genetics laboratory, sequences tumour and normal DNA side by side and identifies the patient-specific neoantigens that personalised vaccines are built on.

## Summary

CeGaT has run genetic analyses for medical, research and pharmaceutical customers since 2009. Its tumour diagnostics compare tumour and germline sequences to find somatic alterations and, from them, patient-specific neoantigens; the personalised peptide vaccine programme at CeCurio, the MVZ Tübingen oncology practice, draws on that work. Physician-ordered.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Tags: ctgov-sponsor; fcct-directory
- HQ: Tübingen, Germany
- Type: diagnostics
- Website: https://cegat.com/

## Sources

- Official website: https://cegat.com/
- Listed on Future of Cancer Care Today (Sijbrandij Foundation): https://sijbrandijfoundation.org/fcct

## Connected records

- technologies: [Comprehensive genomic profiling](https://onco.cc/technologies/cgp/), [Personalised neoantigen (mRNA) vaccines](https://onco.cc/technologies/neoantigen-mrna-vaccine/)

---
JSON: https://onco.cc/api/v1/entities/cegat.json